News • Molecular imaging
HER2-positive breast cancer: PET/CT technique shows promise for predicting treatment response
Molecular imaging with ⁶⁸Ga-HER2 PET/CT may provide an early, targeted measure of how well treatment is working in patients with HER2-positive breast cancer, according to new research.






































